{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:44:35Z","timestamp":1783651475046,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pdpdt.2023.103745","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:23:06Z","timestamp":1691562186000},"page":"103745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study"],"prefix":"10.1016","volume":"44","author":[{"given":"Fengmei","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pdpdt.2023.103745_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103635","article-title":"Appetite and satiety control-contribution of gut mechanisms","volume":"13","author":"Feinle-Bisset","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103745_bib0003","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/08164622.2021.1994337","article-title":"The diagnostic value of systemic immune-inflammation index in diabetic macular oedema","volume":"105","author":"Elbeyli","year":"2022","journal-title":"Clin. Exp. Optom."},{"issue":"4","key":"10.1016\/j.pdpdt.2023.103745_bib0004","doi-asserted-by":"crossref","first-page":"e14746","DOI":"10.1111\/dme.14746","article-title":"Treatment patterns and persistence rates with anti-vascular endothelial growth factor treatment for diabetic macular oedema in the UK: a real-world study","volume":"39","author":"Peto","year":"2022","journal-title":"Diabetes Med."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0005","article-title":"Conbercept for treatment of neovascular age-related macular degeneration and visual impairment due to diabetic macular edema or pathologic myopia choroidal neovascularization: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.pdpdt.2023.103745_bib0006","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of Conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2023.103745_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2143082","article-title":"Intravitreal Conbercept injection with and without grid laser photocoagulation in the treatment of diffuse diabetic macular edema in real-life clinical practice","volume":"2016","author":"Xu","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2023.103745_bib0008","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/bjophthalmol-2020-318690","article-title":"Intravitreal Conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study","volume":"106","author":"Liu","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8849730","article-title":"Clinical observation of phacoemulsification combined with intravitreal injection of Conbercept in cataract patients with diabetic macular edema","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0010","first-page":"636","article-title":"One-year outcomes of novel VEGF decoy receptor therapy with intravitreal Conbercept in diabetic retinopathy-induced macular edema","volume":"25","author":"Zhou","year":"2019","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12886-017-0554-8","article-title":"Comparison of 12-month therapeutic effect of Conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study","volume":"17","author":"Xu","year":"2017","journal-title":"BMC Ophthalmol."},{"issue":"11","key":"10.1016\/j.pdpdt.2023.103745_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111126","article-title":"The 2-year leakage index and quantitative microaneurysm results of the RECOVERY study: quantitative ultra-widefield findings in proliferative diabetic retinopathy treated with intravitreal aflibercept","volume":"11","author":"Babiuch","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1374891","article-title":"Comparisons of one to three monthly injections of aflibercept for diabetic macular edema by practical protocol","volume":"2021","author":"Hayashi","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0014","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12886-020-01648-x","article-title":"Clinical effect of Conbercept on improving diabetic macular ischemia by OCT angiography","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Ophthalmol."},{"issue":"35","key":"10.1016\/j.pdpdt.2023.103745_bib0015","doi-asserted-by":"crossref","first-page":"e21992","DOI":"10.1097\/MD.0000000000021992","article-title":"Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA","volume":"99","author":"Ba","year":"2020","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.pdpdt.2023.103745_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4239\/wjd.v4.i6.290","article-title":"Classification of diabetic retinopathy and diabetic macular edema","volume":"4","author":"Wu","year":"2013","journal-title":"World J. Diabetes"},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103745_bib0017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103745_bib0018","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-016-3974-8","article-title":"Diabetic macular oedema: pathophysiology, management challenges and treatment resistance","volume":"59","author":"Bahrami","year":"2016","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.pdpdt.2023.103745_bib0019","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ophtha.2017.03.057","article-title":"Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: a randomized trial","volume":"124","author":"Dugel","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2023.103745_bib0020","first-page":"37","article-title":"Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys","volume":"14","author":"Zhang","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0021","first-page":"2311","article-title":"Profile of Conbercept in the treatment of neovascular age-related macular degeneration","volume":"9","author":"Lu","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0022","unstructured":"Y. Zhang, J. Yao, Y. Quan, J. Wang, Y. Xing, A. Zhou, [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography], Nan Fang Yi Ke Da Xue Xue Bao 41(10) (2021) 1501\u20131508."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0023","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1038\/s41598-021-83811-y","article-title":"Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema","volume":"11","author":"Hirano","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40123-019-00224-x","article-title":"Clinical outcomes of a treat and extend regimen with intravitreal aflibercept injections in patients with diabetic macular edema: experience in clinical practice","volume":"9","author":"Curry","year":"2020","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2132037","article-title":"Quantitative analysis of retinal microvascular perfusion and novel biomarkers of the treatment response in diabetic macular edema","volume":"2020","author":"Park","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0026","doi-asserted-by":"crossref","first-page":"23398","DOI":"10.1038\/s41598-021-02859-y","article-title":"Differentiating features of OCT angiography in diabetic macular edema","volume":"11","author":"Mirshahi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0027","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.2147\/OPTH.S325037","article-title":"Choroidal blood flow after intravitreal ranibizumab in vitrectomized and non-vitrectomized eyes with diabetic macular edema","volume":"15","author":"Pessoa","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0028","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.2147\/OPTH.S270410","article-title":"The effect of anti-vascular endothelial growth factor on retinal microvascular changes in diabetic macular edema using swept-source optical coherence tomography angiography","volume":"14","author":"Pongsachareonnont","year":"2020","journal-title":"Clin. Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2023.103745_bib0029","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ceo.13966","article-title":"Mean macular intercapillary area in eyes with diabetic macular oedema after anti-vascular endothelial growth factor therapy and its association with treatment response","volume":"49","author":"Sorour","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2023.103745_bib0030","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","article-title":"Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy","volume":"39","author":"Sorour","year":"2019","journal-title":"Int. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2023.103745_bib0031","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.oret.2019.04.027","article-title":"OCT angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema","volume":"3","author":"Hsieh","year":"2019","journal-title":"Ophthalmol. Retina"},{"issue":"11","key":"10.1016\/j.pdpdt.2023.103745_bib0032","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","article-title":"Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response","volume":"123","author":"Lee","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103745_bib0033","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol. Opt."},{"issue":"9","key":"10.1016\/j.pdpdt.2023.103745_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.62.9.41","article-title":"Foveal microvascular integrity association with anti-VEGF treatment response for diabetic macular edema","volume":"62","author":"Huang","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcjo.2020.07.004","article-title":"Macular microvascular changes after intravitreal bevacizumab injection in diabetic macular edema","volume":"56","author":"Mirshahi","year":"2021","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0036","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/OPTH.S285388","article-title":"Early visual functional outcomes and morphological responses to anti-vascular growth factor therapy in diabetic macular oedema using optical coherence tomography angiography","volume":"15","author":"Dabir","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40662-020-00195-2","article-title":"Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography","volume":"7","author":"Sorour","year":"2020","journal-title":"Eye Vis."},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103745_bib0038","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3928\/23258160-20200804-05","article-title":"Twenty-four-month OCTA assessment in diabetic patients undergoing fixed-interval intravitreal aflibercept therapy","volume":"51","author":"Statler","year":"2020","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.pdpdt.2023.103745_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5814165","article-title":"Evaluation of changes in macular perfusion detected by optical coherence tomography angiography following 3 intravitreal monthly bevacizumab injections for diabetic macular edema in the IMPACT study","volume":"2020","author":"Elnahry","year":"2020","journal-title":"J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103745_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00592-019-01424-4","article-title":"Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids","volume":"57","author":"Vujosevic","year":"2020","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40942-019-0192-9","article-title":"Changes in retinal and choriocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiography","volume":"5","author":"Conti","year":"2019","journal-title":"Int. J. Retina Vitreous"},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103745_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.16-20579","article-title":"Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion","volume":"58","author":"Ghasemi Falavarjani","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2023.103745_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40942-019-0167-x","article-title":"Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis","volume":"5","author":"Babiuch","year":"2019","journal-title":"Int. J. Retina Vitreous"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023004726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023004726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T19:28:12Z","timestamp":1733254092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100023004726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"alternative-id":["S1572100023004726"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103745","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103745"}}